Cargando…
Do Certain Biomarkers Predict Adverse Outcomes in Coronavirus Disease 2019?
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Given the rapid spread of the disease, the World Health Organization (WHO) declared the 2019 - 2020 coronavirus outbreak a Public Health Emergency of International...
Autores principales: | Narvel, Hiba, Sayed, Anam, Narvel, Nida, Yakkali, Shreyas, Katchi, Tasleem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8110220/ https://www.ncbi.nlm.nih.gov/pubmed/34007357 http://dx.doi.org/10.14740/jocmr4254 |
Ejemplares similares
-
How SOLID is the immune system’s response to the deadly duo of lung cancer and SARS-CoV-2?
por: Narvel, Hiba, et al.
Publicado: (2022) -
Primary central nervous system lymphoma: treatment access and outcomes in HIV positive patients in a minority rich cohort
por: Narvel, Hiba, et al.
Publicado: (2023) -
Multisystem Inflammatory Syndrome in Adults or Hemophagocytic Lymphohistiocytosis: A Clinical Conundrum in Fully Vaccinated Adults With Breakthrough COVID-19 Infections
por: Narvel, Hiba, et al.
Publicado: (2022) -
Obstructive Jaundice as the Initial Manifestation of Gastric Adenocarcinoma
por: Ansari, Shehbaz M, et al.
Publicado: (2022) -
Diagnosis and treatment of CD20 negative B cell lymphomas
por: Katchi, Tasleem, et al.
Publicado: (2017)